October 27, 2023
Sumitomo Pharma will grant AlphaNavi Pharma the rights to exclusively develop, manufacture, and commercialize its novel investigational DSP-3905 worldwide for neuropathic pain, they said on October 25. AlphaNavi is a drug discovery company established in 2019 as a carve-out startup...read more